Welcome to the e-CCO Library!

P472: Impact of anti-TNF-alfa therapy on colectomy rates and indications for surgery in Ulcerative Colitis: Comparison of two patient cohorts from 2005 to 2007 and 2014 to 2016
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Kolehmainen1*, A. Lepistö2, M. Färkkilä1,3

Created: Thursday, 21 February 2019, 9:14 AM
P472: Original and biosimilar infliximab: Are they two faces of the same coin? The experience from a pioneer European center
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cúrdia Gonçalves T.*1, Monteiro S.1, Dias de Castro F.1, Moreira M.J.1, Cotter J.1,2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P472: Payer addressable burden of Crohn’s disease in patients treated with ustekinumab and vedolizumab in the United States
Year: 2021
Source: ECCO'21 Virtual
Authors: Ghosh, T.(1);Smith, I.(2);Fehr, J.(2);Davidson, J.(2);Fan, T.(3);Candela, N.(4);Tsang, C.(5);Koch, T.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P473 Long-term follow-up of switching from original adalimumab to adalimumab biosimilar: real-world data in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Padilla Suarez, K. Webb, N. Persad, J. Sercombe, E. Tyler, K. Klimova

Created: Thursday, 30 January 2020, 10:12 AM
P473: Clinical and biochemical factors that influence response in inflammatory disease patients receiving tacrolimus
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Rodríguez - Lago*1, 2, O. Merino2, 3, O. Nantes2, 4, C. Muñoz2, 5, U. Aguirre6, J. L. Cabriada1, 2

Created: Friday, 22 February 2019, 9:49 AM
P473: Contrasting the use of 5-ASA in patients with Ulcerative Colitis and Crohn's Disease: A cross-sectional analysis at a tertiary care IBD clinic
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Alkhattabi*, V. Jairath, N. Chande, P. Walton-Mennill, J. Gregor

Created: Thursday, 21 February 2019, 9:14 AM
P473: Corticosteroid-free clinical remission rates with guselkumab maintenance therapy in patients with moderately to severely active Crohn's disease: Week 48 analyses from the phase 2 GALAXI 1 study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: D'Haens, G.(1)*;Afzali, A.(2);Filip, R.(3);Rolim, A.(4);Terry, N.A.(5);Salese, L.(5);Sahoo, A.(5);Frustaci, M.E.(6);Yang, Z.(6);Andrews, J.M.(7);Danese, S.(8);Hisamatsu, T.(9);
Created: Friday, 14 July 2023, 11:05 AM
P473: Cumulative histological inflammation predicts colorectal neoplasia in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. V. Yvellez1, V. Rai*1, J. Hart2, J. R. Turner2, K. El Jurdi1, D. T. Rubin1

Created: Friday, 22 February 2019, 9:41 AM
P473: How to monitor the withdrawal of maintenance treatment with azathioprine in IBD patients with deep remission: results from a prospective study on multiple non invasive tests
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cassinotti A.*1, Massari A.1, Carmagnola S.1, Molteni P.1, Fociani P.2, Ardizzone S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P473: Real world experience with the Crohn's Disease Exclusion Diet (CDED) in a tertiary IBD clinic
Year: 2022
Source: ECCO'22
Authors: Fliss Isakov, N.(1);Anbar, R.(2);Cooperstein, A.(2);Helbert, G.(2);Hirsch, A.(1);Ron, Y.(1);Thurm, T.(1);Maharshak, N.(1);
Created: Friday, 11 February 2022, 3:52 PM
P473: Ustekinumab and vedolizumab influence on cardiovascular risk factors in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Amiama Roig, C.(1);Suárez Ferrer, C.(1);Poza Cordón, J.(1);Rueda García, J.L.(1);Sánchez Azofra, M.(1);Martín Arranz, E.(1);González Díaz, I.(1);Amor Costa, C.(1);García Ramírez, L.(2);Martín Arranz, M.D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P474 Efficacy and safety of GCAP therapy for UC with PSC
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Ito, S. Murasugi, T. Omori, M. Yonezawa, K. Tokushige

Created: Thursday, 30 January 2020, 10:12 AM
P474: An enzyme-linked immunosorbent assay for therapeutic drug monitoring of vedolizumab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Berger C.1, Semmler J.1, Ruppert J.1, Schulze H.2, Armbruster F.-P.1, Dignass A.2,3, Stein J.*3,4

Created: Wednesday, 20 February 2019, 10:36 AM
P474: Analysis of UC colectomy rates in pre- and post-biologic era in South-East Scotland
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Jenkinson*1, G. R. Jones1, N. Plevris1, M. Lyons2, K. Kirkwood3, C. Lees1

Created: Friday, 22 February 2019, 9:41 AM
P474: Assessing the position of systemic tacrolimus in the treatment of inflammatory bowel disease: systematic review and meta-analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Lie*, J. Kreijne, B. Hansen, J. van der Woude

Created: Friday, 22 February 2019, 9:49 AM
P474: Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Bellanger1*, L. Beaugerie2, A. Amiot3, S. Tezenas du Montcel4, C. Duvoux3, D. Samuel5, F. Carbonnel1

Created: Thursday, 21 February 2019, 9:14 AM
P474: Postoperative disease course after appendectomy as experimental treatment for patients with therapy refractory moderate to severe ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Reijntjes, M.(1)*;Heuthorst, L.(1);Stellingwerf, M.(1);d'Haens, G.R.(2);Bemelman, W.A.(1);Buskens, C.J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P474: Postoperative infectious complications in patients with Inflammatory Bowel Disease: experience of a tertiary center
Year: 2021
Source: ECCO'21 Virtual
Authors: Librero Jiménez, M.(1);Ortega Suazo, E.J.(1);Sánchez Capilla, A.D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P474: Prevalence of fecal incontinence and clinical characteristics of IBD patients in remission and treated with biologics – experience from a tertiary referral center
Year: 2022
Source: ECCO'22
Authors: Jelakovic, M.(1);Turk, N.(1);Brinar, M.(1);Barisic, A.(1);Grgic, D.(1);Cukovic-Cavka, S.(1);Krznaric, Z.(1);
Created: Friday, 11 February 2022, 3:52 PM
P475 Association between disease duration and degree of endoscopic improvement in patients with ulcerative colitis treated with tofacitinib
Year: 2020
Source:

ECCO'20 Vienna

Authors:

W.J. Sandborn1, J.P. Gisbert2, I. Modesto3, C. Su4, D. Quirk4, R. Mundayat3, X. Guo4, M. Chiorean5, W. Reinisch6

Created: Thursday, 30 January 2020, 10:12 AM